Explore

Trendline Trendline
GeneDx Reports Strong Q1 2026 Financial Results and Updates Outlook

GeneDx Reports Strong Q1 2026 Financial Results and Updates Outlook

GeneDx Reports Strong Q1 2026 Financial Results and Updates Outlook
Trendline Trendline
GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook

GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook

GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook
Trendline Trendline
SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine

SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine

SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Trendline Trendline
INOVIO to Announce Q1 2026 Financial Results with Live Webcast

INOVIO to Announce Q1 2026 Financial Results with Live Webcast

INOVIO to Announce Q1 2026 Financial Results with Live Webcast
Trendline Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Trendline Trendline
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
Trendline Trendline
UL Solutions Inc. Reports Strong First Quarter 2026 Financial Results with Significant Margin Expansion

UL Solutions Inc. Reports Strong First Quarter 2026 Financial Results with Significant Margin Expansion

UL Solutions Inc. Reports Strong First Quarter 2026 Financial Results with Significant Margin Expansion
Trendline Trendline
Avalon Holdings Corporation Reports First Quarter Financial Results Highlighting Reduced Losses

Avalon Holdings Corporation Reports First Quarter Financial Results Highlighting Reduced Losses

Avalon Holdings Corporation Reports First Quarter Financial Results Highlighting Reduced Losses
Trendline Trendline
Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks
Trendline Trendline
JELD-WEN Reports Q1 2026 Financial Results, Updates Full Year Guidance

JELD-WEN Reports Q1 2026 Financial Results, Updates Full Year Guidance

JELD-WEN Reports Q1 2026 Financial Results, Updates Full Year Guidance
Trendline Trendline
Duke Energy Reports Q1 2026 Financial Results, Highlights Energy Modernization Strategy

Duke Energy Reports Q1 2026 Financial Results, Highlights Energy Modernization Strategy

Duke Energy Reports Q1 2026 Financial Results, Highlights Energy Modernization Strategy